ALLMedicine™ Acute Disseminated Encephalomyelitis Center

Jan 3rd, 2022 - Background Multiple sclerosis (MS) is primarily a disease of adults. However, MS onset in children accounts for up to 5% of all MS cases. Over the last 10 years, much has been learned about the epidemiology, pathophysiology, diagnosis, and treatme...

Jan 3rd, 2022 - Background Multiple sclerosis (MS) is primarily a disease of adults. However, MS onset in children accounts for up to 5% of all MS cases. Over the last 10 years, much has been learned about the epidemiology, pathophysiology, diagnosis, and treatme...

Dec 25th, 2021 - To raise medical specialists' awareness regarding the severity of possible complications of levamisole administration and demonstrate the role of accurate medical history collection in differential diagnosis. Levamisole, an anthelmintic drug with ...

Dec 6th, 2021 - To delineate the outcomes of paediatric patients with myelin oligodendrocyte glycoprotein antibody disease (MOGAD). We retrospectively analyzed the clinical characteristics, treatment, and outcomes of 34 paediatric patients with MOGAD from July 20...

Nov 23rd, 2021 - Anti-myelin oligodendrocyte glycoprotein (MOG) antibody can be detected not only in acute disseminated encephalomyelitis or optic neuritis but also in limbic or cortical encephalitis. However, no previous reports have demonstrated a relapsing case...

Jul 20th, 2021 - To establish a large, longitudinal collection of high quality samples and data from subjects with MS, selected other demyelinating diseases (Transverse Myelitis (TM), Neuromyelitis Optica (NMO) or Devic's, Acute Disseminated Encephalomyelitis (ADE...

Dec 5th, 2017 - The International Pediatric Multiple Sclerosis Study Group (IPMSSG) criteria were applied on all included patients who were stratified into the following groups: (1) those with 2 or more non-encephalopathic clinical CNS events (NEE) separated by >...

Sep 30th, 2021 - This young patient is probably presenting with pediatric multiple sclerosis (MS). It is estimated that MS onset before the age of 18 years accounts for 3%-5% of the general population of patients with this autoimmune disease.

Dec 28th, 2020 - NEW YORK (Reuters Health) - Children may develop neurological complications of COVID-19 ranging from mild to severe, a large brain-imaging study confirms. "Different recognizable patterns of brain, cranial nerve, and spinal cord involvement were i...

Apr 1st, 2020 - The first presumptive case of COVID-19-associated acute necrotizing hemorrhagic encephalopathy, a rare para-infectious encephalopathy, was reported. An uncommon complication of influenza and other viral infections, acute necrotizing encephalopathy...

Feb 12th, 2020 - A "milestone" discovery that an antibody is associated with a wider range of life-threatening autoimmune diseases than previously thought offers new hope for improved diagnosis and treatment in children with life-threatening neurologic disorders. ...

Feb 12th, 2020 - A "milestone" discovery that an antibody is associated with a wider range of life-threatening autoimmune diseases than previously thought offers new hope for improved diagnosis and treatment in children with life-threatening neurologic disorders. ...